Epizyme Inc (NASDAQ:EPZM)

1.49
BATS BZX Real-Time Price
As of 12:43pm ET
 -0.01 / -0.67%
Today’s Change
0.41
Today|||52-Week Range
7.79
-40.60%
Year-to-Date
Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More
Jun 29 / Zacks.com - Paid Partner Content
Why Epizyme Stock Is Soaring Today
Jun 27 / MotleyFool.com - Paid Partner Content
Why Adaptimmune Therapeutics Stock Is Popping Today
Jun 27 / MotleyFool.com - Paid Partner Content
Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen
Jun 27 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.50
Today’s open1.49
Day’s range1.49 - 1.50
Volume68,154
Average volume (3 months)3,233,017
Market cap$250.8M
Data as of 12:43pm ET, 07/07/2022

Growth & Valuation

Earnings growth (last year)-6.61%
Earnings growth (this year)+43.57%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+137.45%
P/E ratioNM
Price/Sales6.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OTLKOutlook Therapeutics...+0.01+0.90%
XOMAXOMA Corp+1.42+6.32%
ALDXAldeyra Therapeutics...+0.20+4.71%
RYTMRhythm Pharmaceutica...+0.07+1.48%
Data as of 12:45pm ET, 07/07/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$37.4M
Annual profit (last year)-$251.1M
Net profit margin-670.96%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts